Market Overview

Trade GMED stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
4/06/20Wells FargoMaintainsOverweight50.0
3/27/20Morgan StanleyMaintainsEqual-Weight48.0
3/18/20BTIGUpgradesNeutralBuy46.0
Show more Loading articles...

Earnings View Earnings

Q4 2019 EST Actual Surprise
EPS: 0.520 0.490 -0.0300
Rev: 210.44M 211.67M 1.23M
Q1 2020 EST Actual Surprise
EPS: Expected
2020-04-30
Rev:

Company Profile